RxDoctor Payments Data

Sarah Schell

Psychiatric/Mental Health · Syracuse, NYNPI 1831685791

Payments from drug & device makers

$1,744in general payments, 2019–2025

Across 87 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$329
  • Otsuka America Pharmaceutical, Inc.$247
  • Teva Pharmaceuticals USA, Inc.$243
  • E.r. Squibb & Sons, L.L.C.$202
  • Vanda Pharmaceuticals Inc.$184
  • Alkermes, Inc.$166
  • plus $373 from 9 others

What the payments were for

  • Food & beverage$1,744100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,744 in reported general payments places this provider in the 75th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$3,296
Medicare patients
13
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$41,600
TrintellixVortioxetine Hydrobromide15$6,677
Quetiapine Fumarate ErQuetiapine Fumarate20$1,381
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl28$861
Aripiprazole27$676
Quetiapine Fumarate45$675
Clozapine11$654
Bupropion XlBupropion Hcl49$395
Ziprasidone Hcl13$330
Duloxetine Hcl34$316
Trazodone Hcl72$310
Divalproex Sodium ErDivalproex Sodium14$253
Hydroxyzine Hcl22$241
Sertraline Hcl48$217
Clonazepam45$201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$98$41,60015 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$29$6,67715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →